+44 (0) 20 7079 4399
Call HCA from 8am-8pm Mon-Fri and 9am-5pm Sat
HCA Healthcare UK
Mr Robert Carpenter
MBBS MS FRCS
Breast cancers, Breast Surgery
Breast oncoplastics and endocrine surgery
Mr Robert Carpenter qualified at the Middlesex Hospital in 1980 and subsequently trained in surgical oncology and breast surgery. He gained his FRCS in 1984 and a Masters Degree (Cellular DNA Change in Early Breast Cancer) at the University of London in 1987. His main research interest is in breast cancer molecular biology and he has published widely in this area.Mr Carpenter is Clinical lead in breast surgery and Associate Director of cancer services at Barts Hospital, Clinical Lead for breast surgery at University College London Hospital, Chairman of the Inner East London Multi Disciplinary Team Meeting, and Founder Chairman of the North East London Breast Cancer Tumour Board. In addition, he sits on medical advisory panels for several UK charities, UK steering committees for the TEAM and POETIC clinical trials and is a national committee member of the Sloan (DCIS) project. He is the National Principal Investigator for the Novartis GB-07 clinical trial of neo adjuvant letrozole therapy.Mr Carpenter has pioneered, implemented, audited and published on several innovations in breast cancer diagnosis and management in the UK including One-stop diagnostic breast clinics, Sentinel node biopsy, and Onco-plastic breast surgery. He has also led a charity appeal ('13.5 million) to build the internationally recognised, state of the art, diagnostic breast unit at Barts Hospital which opened in 2003. Mr Carpenter was awarded the NHS Champion of London award in 2004.
To Make an appointment, call HCA on +44(0)20 7079 4399
or click here
Call the contact centre
+44 (0) 20 7079 4399
8am-8pm Mon-Fri, 9am-5pm Sat
Let us call you backCan we call you back at a more convenient time
Email contact centreSend us an email and we will get back to you.
© copyright 2008 - 2017 HCA Healthcare UK.
Registered Name: HCA International Limited; The part of the UK in which it is registered: England and Wales;
Registered Number: 03020522; Registered Office Address: 242 Marylebone Road London NW1 6JL.
£500m has been invested by HCA International in the latest medical technologies and facilities over the last 10 years.
Your hospital will be one of our world-class private hospitals: HCA’s world-class hospitals are accredited by The CHKS Accreditation Unit, a leading provider of healthcare intelligence and quality improvement services. The accreditation is a measure of the overall quality of a hospital and hospitals with CHKS accreditation have been shown to provide a better quality of service.
Your safety will be protected because we have more critical care beds than any other private hospital group: HCA hospitals achieved 100% compliance with all Care Quality Commission inspected outcomes of care in 2011.
Your treatment will be undertaken using the most advanced diagnostic and treatment facilities: Oliver Wyman, Corporate Accounts: Driving quality and value, January 2012.